These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


528 related items for PubMed ID: 12660343

  • 1. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
    Tsai HM.
    J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE, Moake JL, Miyata T, George JN.
    Hematology Am Soc Hematol Educ Program; 2004 Apr; ():407-23. PubMed ID: 15561695
    [Abstract] [Full Text] [Related]

  • 3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 4. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y, Fujita T.
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM.
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL.
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R, Budde U, Oyen F, Angerhaus D, Aumann V, Drewke E, Hassenpflug W, Häberle J, Kentouche K, Kohne E, Kurnik K, Mueller-Wiefel D, Obser T, Santer R, Sykora KW.
    Blood; 2003 Mar 01; 101(5):1845-50. PubMed ID: 12393505
    [Abstract] [Full Text] [Related]

  • 14. von Willebrand factor and thrombotic thrombocytopenic purpura.
    Raife TJ, Montgomery RR.
    Curr Opin Hematol; 2000 Sep 01; 7(5):278-83. PubMed ID: 10961577
    [Abstract] [Full Text] [Related]

  • 15. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M.
    Expert Rev Cardiovasc Ther; 2003 Jul 01; 1(2):243-55. PubMed ID: 15030284
    [Abstract] [Full Text] [Related]

  • 16. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C, Stapenhorst L, Simon T, Budde U, Schneppenheim R, Hoppe B.
    Kidney Int; 2004 Sep 01; 66(3):955-8. PubMed ID: 15327386
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.